Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Medulloblastoma × Tamoxifen × Clear all

Sponsor

Conditions

Breast Neoplasms 69 Carcinoma, Intraductal, Noninfiltrating 9 Breast Carcinoma In Situ 6 Breast Neoplasms, Male 5 Neoplasms 3 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Inflammatory Breast Neoplasms 2 Sleep Wake Disorders 1 Risk Reduction Behavior 1 Obesity 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Mastodynia 1 Glioma 1 Fibrocystic Breast Disease 1 Fibroadenoma 1 Fatigue 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Desmoid Tumors 1 Cystic Fibrosis 1 Cystadenocarcinoma, Serous 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Arthralgia 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Vincristine 8 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 7 Cisplatin 6 X-Rays 5 Specimen Handling 5 Radiotherapy 5 Phantoms, Imaging 5 Irinotecan 5 Carboplatin 5 Temozolomide 4 Radiation 4 Platinum 4 Nuclear Medicine Department, Hospital 4 Lomustine 4 palbociclib 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Etoposide 3 Biopsy 3 1,2-diaminocyclohexaneplatinum II citrate 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 sonidegib 2 selpercatinib 2 olaparib 2 merphos 2 larotrectinib 2 ivosidenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡